Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2022 Filed Mar 31, 2022 00:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000039 · wf-form4_164868686294471.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2022 Filed Mar 31, 2022 00:34 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,000 | $25.09 | $250,900.00 |
DisclosureSEC source: 0001759655-22-000039 · wf-form4_164868686294471.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.83 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 28, 2022 Filed Mar 31, 2022 00:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-22-000039 · wf-form4_164868686294471.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2022 Filed Mar 31, 2022 00:33 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000038 · wf-form4_164868680700946.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,705,692 Underlying: Common Stock · 20,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2022 Filed Mar 31, 2022 00:33 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 20,000 | $25.09 | $501,800.00 |
DisclosureSEC source: 0001759655-22-000038 · wf-form4_164868680700946.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.94 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 28, 2022 Filed Mar 31, 2022 00:33 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 20,000 | $2.00 | $40,000.00 |
DisclosureSEC source: 0001759655-22-000038 · wf-form4_164868680700946.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:36 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000023 · wf-form4_164572775715855.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725,692 Underlying: Common Stock · 20,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:36 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 20,000 | $25.30 | $505,980.00 |
DisclosureSEC source: 0001759655-22-000023 · wf-form4_164572775715855.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.86 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:36 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 20,000 | $2.00 | $40,000.00 |
DisclosureSEC source: 0001759655-22-000023 · wf-form4_164572775715855.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000021 · wf-form4_164572764763309.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,000 | $25.32 | $253,160.00 |
DisclosureSEC source: 0001759655-22-000021 · wf-form4_164572764763309.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.83 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-22-000021 · wf-form4_164572764763309.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:59 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,288 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000019 · wf-form4_164486875463288.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,745,692 Underlying: Common Stock · 5,288 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:59 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 188 | $25.02 | $4,703.76 |
DisclosureSEC source: 0001759655-22-000019 · wf-form4_164486875463288.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:59 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 5,100 | $25.01 | $127,551.00 |
DisclosureSEC source: 0001759655-22-000019 · wf-form4_164486875463288.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,579 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:59 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 5,288 | $2.00 | $10,576.00 |
DisclosureSEC source: 0001759655-22-000019 · wf-form4_164486875463288.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:20 UTC |
Sherman Jeffrey ScottEVP, CFO and CAO
|
GrantStock Option (Right to Purchase) · Derivative | 235,128 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001759655-22-000009 · wf-form4_164159402168915.xml · derivative · entry 2 Sherman Jeffrey Scott · CIK 0001463145 · EVP, CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,128 Underlying: Common Stock · 235,128 shares Expires 2032-01-05 F2 · derivative.exercise_date: Represents options granted under the Issuer's 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:20 UTC |
Sherman Jeffrey ScottEVP, CFO and CAO
|
GrantCommon Stock, $0.01 par value per share | 61,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000009 · wf-form4_164159402168915.xml · nonDerivative · entry 1 Sherman Jeffrey Scott · CIK 0001463145 · EVP, CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,307 F1 · security: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:24 UTC |
Mountcastle DavidChief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 21,554 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000005 · wf-form4_164159063368919.xml · derivative · entry 3 Mountcastle David · CIK 0001858396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,774 Underlying: Common Stock · 21,554 shares Expires 2029-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options to purchase shares of common stock of the Issuer were granted under the Second Amended and Restated PH Group Parent Corp. Stock Option Plan. 62,508 of the stock options are fully vested and exercisable. The remaining stock options vest as follows: 10,778 vest on April 1, 2022, 17,244 vest on April 29, 2022 and 17,244 vest on October 29, 2022. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:24 UTC |
Mountcastle DavidChief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 16,391 | $25.53 | $418,429.45 |
DisclosureSEC source: 0001759655-22-000005 · wf-form4_164159063368919.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,989 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.96 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:24 UTC |
Mountcastle DavidChief Financial Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 21,554 | $2.00 | $43,108.00 |
DisclosureSEC source: 0001759655-22-000005 · wf-form4_164159063368919.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Feb 14, 2022 14:55 UTC |
Butler Jeffrey BDirector
|
GiftCommon Stock | 290,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000016 · wf-form5_164485053463837.xml · nonDerivative · entry 3 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,652,212 F2 · kind: On December 28, 2021, the reporting person transferred 290,000 shares of the Issuer's common stock to the Butler Ventures Fund, Inc., a charitable foundation of which the reporting person and his spouse are directors. The reporting person has voting and investment power over the securities owned by the foundation. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:02 UTC |
Mountcastle DavidChief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 25,000 | $25.04 | $625,925.00 |
DisclosureSEC source: 0001759655-21-000048 · wf-form4_164030049716295.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:01 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-21-000047 · wf-form4_164030044158915.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:01 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,000 | $25.15 | $251,450.00 |
DisclosureSEC source: 0001759655-21-000047 · wf-form4_164030044158915.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:01 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-21-000047 · wf-form4_164030044158915.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-21-000046 · wf-form4_164030039631461.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750,980 Underlying: Common Stock · 20,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 20,000 | $25.14 | $502,720.00 |
DisclosureSEC source: 0001759655-21-000046 · wf-form4_164030039631461.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.60 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 20,000 | $2.00 | $40,000.00 |
DisclosureSEC source: 0001759655-21-000046 · wf-form4_164030039631461.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:06 UTC |
MBD Advisors, L.L.C.10% owner
|
SaleCommon Stock | 2,505,732 | $27.70 | $69,396,247.74 |
DisclosureSEC source: 0000895345-21-000987 · form4.xml · nonDerivative · entry 1 MBD Advisors, L.L.C. · CIK 0001589295 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 28,676,936 F1 · ownership.direct: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman Sachs & Co. LLC ("Goldman Sachs"), MBD 2013, L.P. ("MBD Onshore"), MBD 2013 Offshore, L.P. ("MBD Offshore"), MBD 2013 Holdings, L.P. ("MBD Holdings"), Broad Street Principal Investments, L.L.C. ("Broad Street"), Bridge Street 2013, L.P. ("Bridge Street Onshore"), Bridge Street 2013 Offshore, L.P. ("Bridge Street Offshore"), Bridge Street 2013 Holdings, L.P. ("Bridge Street Holdings" and, together with MBD Onshore, MBD Offshore, MBD Holdings, Broad Street, Bridge Street Onshore and Bridge Street Offshore, the "GS Funds"), MBD Advisors, L.L.C. ("MBD Advisors"), and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street Advisors" and, together with GS Group, Goldman Sachs, the GS Funds and MBD Advisors, the "Reporting Persons"). F2 · ownership.direct: On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including 26,052,158 shares of Common Stock to Broad Street, 3,231,238 shares of Common Stock to Bridge Street Holdings and 1,228,697 shares of Common Stock to MBD Holdings. F3 · ownership.direct: Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock. F4 · ownership.direct: As of November 22, 2021, as a result of the Offering, Broad Street owned 23,912,688 shares of Common Stock, MBD Holdings owned 1,127,793 shares of Common Stock and Bridge Street Holdings owned 2,965,880 shares of Common Stock. Because of the relationships among the Reporting Persons, each of GS Group and Goldman Sachs may be deemed a beneficial owner of all such shares of Common Stock, MBD Advisors, MBD Onshore and MBD Offshore may be deemed a beneficial owner of the shares held by MBD 2013 Holdings and Bridge Street Advisors, Bridge Street Onshore and Bridge Street Offshore may be deemed a beneficial owner of the shares held by Bridge Street Holdings. Affiliates of Goldman Sachs and GS Group are the general partner, managing general partner, managing partner, managing member or member of the GS Funds. Each of Goldman Sachs and Broad Street is a subsidiary of GS Group. Goldman Sachs is the investment manager of certain of the GS Funds. F5 · ownership.direct: The Reporting Persons disclaim beneficial ownership of all shares of Common Stock except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F6 · ownership.direct: Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. Read SEC document |
| November 23, 2021 Filed Nov 25, 2021 02:07 UTC |
BERNSTEIN JEFFREY DANIELDirector
|
SaleCommon Stock | 2,505,732 | $27.70 | $69,396,247.74 |
DisclosureSEC source: 0000895345-21-000988 · form4.xml · nonDerivative · entry 1 BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 28,676,936 F1 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. F2 · ownership.direct: On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including an aggregate 30,512,093 shares of Common Stock to the GS Funds (as defined below). F3 · ownership.direct: Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock. F4 · ownership.direct: As of November 22, 2021, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 28,006,361 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:03 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 339,062 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000950103-21-018642 · dp162533_4-morris.xml · derivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,540,620 Underlying: Common Stock · 339,062 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:03 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock, $0.01 par value per share | 339,062 | $27.70 | $9,390,322.09 |
DisclosureSEC source: 0000950103-21-018642 · dp162533_4-morris.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: This sale was effected pursuant to a public secondary offering of shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. on November 23, 2021. F2 · price: This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:03 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock, $0.01 par value per share | 339,062 | $2.00 | $678,124.00 |
DisclosureSEC source: 0000950103-21-018642 · dp162533_4-morris.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 18:15 UTC |
Pamplona Capital Partners III, L.P.10% owner
Pamplona Equity Advisors III Ltd10% owner
Pamplona PE Investments Malta Ltd10% owner
Pamplona Capital Management, LLP10% owner
Pamplona Capital Management, LLC10% owner
Halsted John C.10% owner
Knaster Alexander M10% owner
|
SaleCommon Stock | 1,791,175 | $27.70 | $49,606,591.63 |
DisclosureSEC source: 0000905718-21-001539 · privia_fm4nov232021.xml · nonDerivative · entry 1 Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner Halsted John C. · CIK 0001844403 · 10% owner Knaster Alexander M · CIK 0001308574 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Foonotes Disclosed balance after: 20,019,808 F2 · price: Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), and in connection with the public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, the Company sold 6,000,000 shares (excluding 900,000 additional shares which the underwriters have the right to purchase) of Common Stock pursuant to the final prospectus filed by the Company on November 16, 2021, which offering was consummated on November 23, 2021 (the "Public Offering"). The amount above represents the $30.62 public maximum offering price per share of Common Stock in the Public Offering less the effective public offering discount and underwriting discount of $2.93 per share of Common Stock. The shares sold were held by a private investor group, which includes Pamplona Capital Partners III, L.P. F1 · ownership.direct: This statement is being filed by (i) Pamplona Capital Partners III, L.P., (ii) Pamplona Equity Advisors III Ltd, (iii) Pamplona PE Investments Malta Limited, (iv) Pamplona Capital Management LLP, (v) Pamplona Capital Management LLC, (vi) John C. Halsted, and (vii) Alexander Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.direct: As of November 23, 2021, as a result of the Public Offering, the Reporting Persons may be deemed to beneficially own indirectly 20,019,808 shares of Common Stock by reason of the shares in the Company held by Pamplona Capital Partners III, L.P. Pamplona Capital Partners III, L.P. is controlled by Pamplona Equity Advisors III Ltd, its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to Pamplona Capital Partners III, L.P. Pamplona Capital Management LLP, and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander Knaster are the principals of the Pamplona Manager Entities. F4 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P., (ii) Pamplona Equity Advisors III Ltd, (iii) Pamplona PE Investments Malta Limited, (iv) Pamplona Capital Management LLP, (v) Pamplona Capital Management LLC, (vi) John C. Halsted, and (vii) Alexander Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.nature: As of November 23, 2021, as a result of the Public Offering, the Reporting Persons may be deemed to beneficially own indirectly 20,019,808 shares of Common Stock by reason of the shares in the Company held by Pamplona Capital Partners III, L.P. Pamplona Capital Partners III, L.P. is controlled by Pamplona Equity Advisors III Ltd, its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to Pamplona Capital Partners III, L.P. Pamplona Capital Management LLP, and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander Knaster are the principals of the Pamplona Manager Entities. F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:14 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 568,055 | $27.70 | $15,732,283.23 |
DisclosureSEC source: 0000950103-21-018645 · dp162531_4-sullivan.xml · nonDerivative · entry 2 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,349,104 F1 · kind: This sale was effected pursuant to a public secondary offering of shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. on November 23, 2021. F2 · price: This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. F3 · balance_after: Includes 6,917,159 shares of Common Stock received by Brighton Family, LLC in a pro rata distribution of Common Stock by Brighton Health Group Holdings, Inc. to its members on May 11, 2021 less the number of shares sold as reflected in this Form 4. F4 · ownership.nature: Represents Common Stock sold by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the Common Stock held by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:11 UTC |
Butler Jeffrey BDirector
|
SaleCommon Stock, $0.01 par value per share | 429,877 | $27.70 | $11,905,443.52 |
DisclosureSEC source: 0000950103-21-018644 · dp162532_4-butler.xml · nonDerivative · entry 1 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,812,312 F1 · kind: This sale was effected pursuant to a public secondary offering of shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. on November 23, 2021. F2 · price: This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. F3 · balance_after: Includes 5,234,580 shares of Common Stock of Privia Health Group, Inc. received by the reporting person in a pro rata distribution of Common Stock by Brighton Health Group Holdings, Inc. to its members on May 11, 2021 less the number of shares sold as reflected in this Form 4. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:08 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 28,910 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000950103-21-018643 · dp162535_4-bartrum.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,300 Underlying: Common Stock · 28,910 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:08 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 28,910 | $27.70 | $800,662.45 |
DisclosureSEC source: 0000950103-21-018643 · dp162535_4-bartrum.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,391 F1 · kind: This sale was effected pursuant to a public secondary offering of shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. on November 23, 2021. F2 · price: This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:08 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 28,910 | $2.00 | $57,820.00 |
DisclosureSEC source: 0000950103-21-018643 · dp162535_4-bartrum.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 110,104 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000950103-21-018641 · dp162534_4-mehotra.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,770,980 Underlying: Common Stock · 110,104 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 157,929 | $27.70 | $4,373,843.66 |
DisclosureSEC source: 0000950103-21-018641 · dp162534_4-mehotra.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: This sale was effected pursuant to a public secondary offering of shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. on November 23, 2021. F2 · price: This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 23:00 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 110,104 | $2.00 | $220,208.00 |
DisclosureSEC source: 0000950103-21-018641 · dp162534_4-mehotra.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 25, 2021 02:05 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
Bridge Street 2013 Holdings, L.P.10% owner
Bridge Street 2013 Offshore, L.P.10% owner
Bridge Street 2013, L.P.10% owner
MBD 2013 Holdings, L.P.10% owner
MBD 2013 Offshore, L.P.10% owner
MBD 2013, L.P.10% owner
|
SaleCommon Stock | 2,505,732 | $27.70 | $69,396,247.74 |
DisclosureSEC source: 0000895345-21-000986 · form4.xml · nonDerivative · entry 1 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO. LLC · CIK 0000769993 · 10% owner Broad Street Principal Investments, L.L.C. · CIK 0001575993 · 10% owner Bridge Street 2013 Holdings, L.P. · CIK 0001615711 · 10% owner Bridge Street 2013 Offshore, L.P. · CIK 0001572491 · 10% owner Bridge Street 2013, L.P. · CIK 0001572490 · 10% owner Bridge Street Opportunity Advisors, L.L.C. · CIK 0001615636 · 10% owner MBD 2013 Holdings, L.P. · CIK 0001615732 · 10% owner MBD 2013 Offshore, L.P. · CIK 0001572502 · 10% owner MBD 2013, L.P. · CIK 0001572501 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 28,676,936 F1 · ownership.direct: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman Sachs & Co. LLC ("Goldman Sachs"), MBD 2013, L.P. ("MBD Onshore"), MBD 2013 Offshore, L.P. ("MBD Offshore"), MBD 2013 Holdings, L.P. ("MBD Holdings"), Broad Street Principal Investments, L.L.C. ("Broad Street"), Bridge Street 2013, L.P. ("Bridge Street Onshore"), Bridge Street 2013 Offshore, L.P. ("Bridge Street Offshore"), Bridge Street 2013 Holdings, L.P. ("Bridge Street Holdings" and, together with MBD Onshore, MBD Offshore, MBD Holdings, Broad Street, Bridge Street Onshore and Bridge Street Offshore, the "GS Funds"), MBD Advisors, L.L.C. ("MBD Advisors"), and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street Advisors" and, together with GS Group, Goldman Sachs, the GS Funds and MBD Advisors, the "Reporting Persons"). F2 · ownership.direct: On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including 26,052,158 shares of Common Stock to Broad Street, 3,231,238 shares of Common Stock to Bridge Street Holdings and 1,228,697 shares of Common Stock to MBD Holdings. F3 · ownership.direct: Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock. F4 · ownership.direct: As of November 22, 2021, as a result of the Offering, Broad Street owned 23,912,688 shares of Common Stock, MBD Holdings owned 1,127,793 shares of Common Stock and Bridge Street Holdings owned 2,965,880 shares of Common Stock. Because of the relationships among the Reporting Persons, each of GS Group and Goldman Sachs may be deemed a beneficial owner of all such shares of Common Stock, MBD Advisors, MBD Onshore and MBD Offshore may be deemed a beneficial owner of the shares held by MBD 2013 Holdings and Bridge Street Advisors, Bridge Street Onshore and Bridge Street Offshore may be deemed a beneficial owner of the shares held by Bridge Street Holdings. Affiliates of Goldman Sachs and GS Group are the general partner, managing general partner, managing partner, managing member or member of the GS Funds. Each of Goldman Sachs and Broad Street is a subsidiary of GS Group. Goldman Sachs is the investment manager of certain of the GS Funds. F5 · ownership.direct: The Reporting Persons disclaim beneficial ownership of all shares of Common Stock except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F6 · ownership.direct: Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 23:18 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 29,228 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000950103-21-018497 · dp162437_4-morris.xml · derivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879,682 Underlying: Common Stock · 29,228 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 23:18 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock, $0.01 par value per share | 29,228 | $28.12 | $821,891.36 |
DisclosureSEC source: 0000950103-21-018497 · dp162437_4-morris.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.62 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 23:18 UTC |
Morris Matthew ShawnDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock, $0.01 par value per share | 29,228 | $2.00 | $58,456.00 |
DisclosureSEC source: 0000950103-21-018497 · dp162437_4-morris.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:04 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-21-000042 · wf-form4_163719022835443.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,881,084 Underlying: Common Stock · 5,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:04 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 4,500 | $30.77 | $138,483.00 |
DisclosureSEC source: 0001759655-21-000042 · wf-form4_163719022835443.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.44 to $31.07 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:04 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 500 | $29.72 | $14,861.00 |
DisclosureSEC source: 0001759655-21-000042 · wf-form4_163719022835443.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,716 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.36 to $29.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.